Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline

Published:2011-08 Issue:2 Volume:179 Page:980-991
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Medeiros Rodrigo,Kitazawa Masashi,Caccamo Antonella,Baglietto-Vargas David,Estrada-Hernandez Tatiana,Cribbs David H.,Fisher Avraham,LaFerla Frank M.

Funder

National Institute on Aging

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference57 articles.

1. Alzheimer's disease;Querfurth;N Engl J Med,2010

2. Alzheimer's disease: clinical trials and drug development;Mangialasche;Lancet Neurol,2010

3. M1 muscarinic agonists target major hallmarks of Alzheimer's disease: the pivotal role of brain M1 receptors;Fisher;Neurodegener Dis,2008

4. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development;Wess;Nat Rev Drug Discov,2007

5. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies;Levey;J Neurosci,1991

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A golden age of muscarinic acetylcholine receptor modulation in neurological diseases;Nature Reviews Drug Discovery;2024-08-14

2. Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis;Proceedings of the National Academy of Sciences;2024-07-31

3. An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission;Molecular Neurobiology;2024-07-16

4. Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer's disease continuum;Alzheimer's & Dementia;2024-07-12

5. Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment;Clinical Drug Investigation;2024-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3